Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Oldham

Showing results (201-210 of 222) with videos related to

Pageof 23
Sort By:
Journal of Medicinal Chemistry|October 30, 1992
New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivativesR H Bradbury, C P Allott, M Dennis, et al.
Journal of Medicinal Chemistry|April 30, 1993
New nonpeptide angiotensin II receptor antagonists. 3. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)pyridine derivativesR H Bradbury, C P Allott, M Dennis, et al.
Annals of Internal Medicine|August 1, 1992
Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilliM A Fischl, G L Daikos, R B Uttamchandani, et al.
Molecular Genetics and Metabolism|July 28, 2020
The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type IA Broomfield, J Sims, J Mercer, et al.
Journal of Medicinal Chemistry|March 6, 1992
New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivativesA P Thomas, C P Allott, K H Gibson, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2006
Design and synthesis of a novel class of dual PPARgamma/delta agonistsIsabel C Gonzalez, Jason Lamar, Fatima Iradier, et al.
Frontiers in Immunology|August 30, 2023
Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activityMary L Faber, Robyn A A Oldham, Archana Thakur, et al.
The Lancet. Psychiatry|October 18, 2020
Characterising neuropsychiatric disorders in patients with COVID-19Mark A Oldham, Arjen J C Slooter, Colm Cunningham, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 6, 2010
Effects of testosterone on skeletal muscle architecture in intermediate-frail and frail elderly menRoss A Atkinson, U Srinivas-Shankar, Stephen A Roberts, et al.
Indoor Air|June 2, 2005
Endotoxin exposure in asthmatic children and matched healthy controls: results of IPEADAM studyG O G Tavernier, G D Fletcher, H C Francis, et al.
Pageof 23

Showing results (201-210 of 222) with videos related to

Sort By:
Pageof 23
Journal of Medicinal Chemistry|October 30, 1992
New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivativesR H Bradbury, C P Allott, M Dennis, et al.
Journal of Medicinal Chemistry|April 30, 1993
New nonpeptide angiotensin II receptor antagonists. 3. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)pyridine derivativesR H Bradbury, C P Allott, M Dennis, et al.
Annals of Internal Medicine|August 1, 1992
Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilliM A Fischl, G L Daikos, R B Uttamchandani, et al.
Molecular Genetics and Metabolism|July 28, 2020
The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type IA Broomfield, J Sims, J Mercer, et al.
Journal of Medicinal Chemistry|March 6, 1992
New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivativesA P Thomas, C P Allott, K H Gibson, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2006
Design and synthesis of a novel class of dual PPARgamma/delta agonistsIsabel C Gonzalez, Jason Lamar, Fatima Iradier, et al.
Frontiers in Immunology|August 30, 2023
Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activityMary L Faber, Robyn A A Oldham, Archana Thakur, et al.
The Lancet. Psychiatry|October 18, 2020
Characterising neuropsychiatric disorders in patients with COVID-19Mark A Oldham, Arjen J C Slooter, Colm Cunningham, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 6, 2010
Effects of testosterone on skeletal muscle architecture in intermediate-frail and frail elderly menRoss A Atkinson, U Srinivas-Shankar, Stephen A Roberts, et al.
Indoor Air|June 2, 2005
Endotoxin exposure in asthmatic children and matched healthy controls: results of IPEADAM studyG O G Tavernier, G D Fletcher, H C Francis, et al.
Pageof 23